Isolated from Populus euphratica rhizosphere soil, and mining their metabolites.

Introduction: The microbial community in desert ecosystems is a vital and highly active component. , one of the dominant genera within this community, exhibits significant capabilities in metabolic degradation and the synthesis of secondary metabolites.

Methods: To investigate the metabolic potential of , two strains of were isolated from rhizosphere soil samples of in the Taklimakan Desert during the initial phase of this study, TRM 70351 and TRM 70361.

Results: The identification of these strains as belonging to the genus was confirmed through 16S rRNA sequencing. All calculated Average Nucleotide Identity (ANI) values were below the 95% cut-off recommended for distinguishing distinct species, and the estimated digital DNA-DNA hybridization (dDDH) values were all below the suggested threshold of 70% for species delineation. Results from phylogenetic, genomic, phenotypic, and chemotaxonomic analyses confirmed that TRM 70351 and TRM 70361 represent two new species within the genus , designated as s sp. nov. and sp. nov. The type strain for sp. nov. is TRM 70351 ( = CCTCC AA 2020049 = LMG 32404), while the type strain for sp. nov. is TRM 70361 ( = CCTCC AA 2020043 = JCM 35793). Notably, Among the identified gene clusters of TRM 70351, cluster 12.1 was predicted to be the biosynthetic gene cluster responsible for producing the aminoglycoside compound streptomycin, exhibiting a similarity of 55%. In this study, HSQC-TOCSY was employed to detect the presence of aminoglycosides in fermentation medium No. 1, while LC-MS/MS was utilized to analyze the molecular fragments of neomycin and streptomycin in the alkaline aqueous phase sample of the fermentation product. The mixture was eluted using methanol and ammonia water in a 3:1 ratio, leading to the further separation of the compounds daidzein and Tridec-1-ene.

Discussion: This study has enhanced the species resources of and the diversity of aminoglycoside compound-producing bacteria. TRM 70351 exhibited unique metabolic potential, indicating that further studies could be conducted in the future.